In this edition of Null and Noteworthy, tests of intranasal oxytocin and an Angelman syndrome treatment fail to see results.
Spectrum: Autism Research News
An autism brain imaging study published seven years ago received an expression of concern last month after its authors failed to uphold a promise to make their raw data freely available.
Studies of autism subtypes rarely validate their results, and this has led to a proliferation of autism subtypes of questionable utility. But reliable subtyping can help improve the prognosis for and care of autistic people.
Conflicts of interest and methodological issues sully a study published 18 July in the Journal of Autism and Developmental Disorders, autism researchers say.
In this edition of Null and Noteworthy, researchers open the case on acetaminophen and close it on oxytocin.
Spectrum spoke to the researchers who uncovered an error in autism screening guidelines that have been in use for nearly a decade.
After a study revised a popular measure for alexithymia, it was pulled for copyright infringement because the authors did not pay a $40 fee or obtain permission to use the measure.
An expanding collection of websites compiles up-to-date information on the characteristics of people with mutations in genes linked to autism and other conditions.
Studies of autism treatments rarely report adverse events, and the scientists involved often fail to disclose their conflicts of interest.
To address racial disparities in autism diagnosis and outcomes, we need more Black autism researchers and clinicians. Here are some tips to help recruit and train them.